Our collaborative learning environment ensures we will remain nimble and distinctive as a national leader in biomedical discovery, healthcare and training.  As we integrate expertise and data, we will expand and create new research capabilities to make discoveries and get them quickly to patients and our community. 

Examples of Discovering, Learning, and Sharing:

  • Leveraging Vanderbilt’s Precision Medicine Initiative and data coordination center framework to advance robust clinically annotated, genomic data to support basic, clinical and population research; and, identify subsets of patients with distinct genetic causes for common disease and/or adverse drug reactions (many examples from which to choose relative to the audience).
  • Systems to support learning-working teams – QuizTime, a smartphone application designed to improve decision-making processes.  Piloting the application to deliver opioid training as part of continuing medical education (CME) activities.  Goal is to better prepare learners across the continuum to practice medicine in a rapidly changing health care environment. 
  • The Medical Innovators Development Program (MIDP) is a new four-year PhD to MD training program tailored to engineers and applied scientists with existing PhD degrees.  Fills an unmet need for applied physician-scientists who can solve clinical problems by translating discoveries in imaging, informatics and systems design, and/or medical devices into valuable innovation that will improve the lives of our patients.  The MIDP learners will engage with faculty from each of these respective Vanderbilt schools, as well as from successful entrepreneurs from across the nation. The specialized training will allow graduates to generate impact spanning the spheres of academia, non-profits, government, and industry.
  • The American health care system is shifting its focus from providing health care services to optimizing the health of individuals and communities. VUMC is focused on the development of new strategies for working with an increasingly diverse population and addressing disparities in etiology of disease, health care access and patient outcomes associated with factors such as race, gender, sexual orientation, primary language, and socioeconomic status.
  • Expanding and further integrating neuroscience and behavioral health research across Vanderbilt, leveraging new commitments and leadership in Vanderbilt Kennedy Center, Vanderbilt Brain Institute, Departments of Neurology, Psychiatry, Pediatrics, and Pharmacology, and Vanderbilt University Institute of Imaging Science.  In any picture of health, a core finding is that behavior is central to many, maybe to most of our nation’s leading health concerns, such as heart disease, stroke, lung disease, obesity, drug abuse, alcoholism, depression, neurological disorders and many others.
  • Globalization has increased the spread of infectious disease and our ability to manage public heath depends on scientific breakthroughs in the fields of microbiology and immunology, which are fields at the nexus of basic research, clinical care and population health.  Advances in our understanding of the immune system are enabling the treatment of previously intractable diseases such as cancer and auto-immune-based disorders.  We are developing a new trans-institutional framework for infection and immunology research including significant investments in microbiology/microbiome science and immunology.